Clinical trials in Huelva – page 6

86 clinical trials in Huelva, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Huelva at a glance

clinical trials

Research sites0

Quick filters

86 trials in Huelva

Open in trial search

Paresis

Not recruiting

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Sponsor:Merz Pharmaceuticals GmbH

Contact Research Centre

HIV infection

Not recruiting

Study Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults

Registered drugNo placebo

Study Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bictegravir
Sponsor:Fundacion Seimc Gesida

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Study of Atezolizumab Treatment Before Surgery in Patients with Bladder Cancer or Upper Urinary Tract Cancer

Registered drugNo placebo

Study of Atezolizumab Treatment Before Surgery in Patients with Bladder Cancer or Upper Urinary Tract Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Queen Mary University Of London

Contact Research Centre

Cardiomyopathy+1

Not recruiting

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Investigational

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Autologous Bone Marrow-Derived Adult Mononuclear Cells, Not Expanded
Sponsor:Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud

Contact Research Centre

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Azilsartan Medoxomil
Sponsor:Novartis Pharma AG

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Squamous cell carcinoma of lung+3

Not recruiting

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Mirodenafil Dihydrochloride
Sponsor:Aribio Co. Ltd.

Contact Research Centre

Bacterial infection

Not recruiting

Study Comparing 7-Day and 14-Day Treatment with Vancomycin, Linezolid, and Daptomycin for Patients with Uncomplicated Enterococcal Blood Infections

Registered drugNo placebo

Study Comparing 7-Day and 14-Day Treatment with Vancomycin, Linezolid, and Daptomycin for Patients with Uncomplicated Enterococcal Blood Infections

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Amoxicillin Sodium
Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Contact Research Centre

Bacterial infection

Not recruiting

Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

Registered drugNo placebo

Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ertapenem Sodium
Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Contact Research Centre

Cardiac amyloidosis+1

Not recruiting

Study on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis

Registered drugNo placebo

Study on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Patisiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Huelva

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on cardiovascular diseases include studies evaluating new treatments for coronary artery disease and innovative approaches to prevent major cardiovascular events. Research encompasses antiplatelet therapy optimization and novel lipid-lowering interventions.

Coronary Artery Disease Management
Cardiovascular Event Prevention
Antiplatelet Therapy Studies

02 Oncology Studies

Groundbreaking research in cancer treatment addresses multiple types of malignancies, with particular focus on breast cancer and lung cancer. Studies evaluate innovative therapies including immunotherapy combinations and targeted treatments.

Breast Cancer Therapeutics
Lung Cancer Treatments
Pancreatic Cancer Research

03 Gastrointestinal Disorders

Research initiatives in inflammatory bowel diseases focus on novel therapeutic approaches for Crohn's disease and ulcerative colitis. Studies evaluate new medications aimed at improving disease management and patient outcomes.

Crohn's Disease Therapies
Ulcerative Colitis Treatment
Digestive System Disorders

04 Neurodegenerative Conditions

Studies focusing on Alzheimer's disease and other neurodegenerative conditions aim to evaluate new therapeutic approaches for early intervention and disease modification.

Early Alzheimer's Treatment
Disease-Modifying Therapies
Cognitive Function Studies

Back to Spain All countries